NET PROFIT (x1000 NOK)
EMPLOYEES
Vicore Pharma Holding AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
450
|
2,499
|
6 |
Earnings before taxes |
-273,185
|
-289,383
|
-154,327 |
EBITDA |
-271,825
|
-284,004 | |
Total assets |
319,725
|
439,989
|
425,866 |
Current assets |
255,198
|
368,567
|
343,453 |
Current liabilities |
43,788
|
63,945
|
46,402 |
Equity capital |
273,447
|
373,818
|
371,388 |
- share capital |
38,711
|
34,991
|
26,281 |
Employees (average) |
21
|
16
|
13 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
85.5%
|
85.0%
|
87.2% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-85.3%
|
-65.2%
|
-36.2% |
Current ratio |
582.8%
|
576.4%
|
740.2% |
Return on equity (ROE) |
-99.9%
|
-77.4%
|
-41.6% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
5
|
3
|
5 |
Chg. No. of employees % |
31%
|
23%
|
63% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.